
Page#1
GARTNER, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(IN THOUSANDS, EXCEPT SHARE DATA)
December 31,
2019 2018
ASSETS
Current assets:
Cash and cash equivalents $ 280,836 $ 156,368
Fees receivable, net of allowances of $8,000 and $7,700, respectively 1,326,012 1,255,118
Deferred commissions 265,867 235,016
Prepaid expenses and other current assets 146,026 165,237
Total current assets 2,018,741 1,811,739
Property, equipment and leasehold improvements, net 344,579 267,665
Operating lease right-of-use assets (cid:26)(cid:19)(cid:21)(cid:15)(cid:28)(cid:20)(cid:25) (cid:178)
Goodwill 2,937,726 2,923,136
Intangible assets, net 925,087 1,042,565
Other assets 222,245 156,369
Total Assets $ 7,151,294 $ 6,201,474
LIABILITIES AND STOCKHOLDERS’ EQUITY 
Current liabilities:
Accounts payable and accrued liabilities $ 788,796 $ 710,113
Deferred revenues 1,928,020 1,745,244
Current portion of long-term debt 139,718 165,578
Total current liabilities 2,856,534 2,620,935
Long-term debt, net of deferred financing fees 2,043,888 2,116,109
Operating lease liabilities (cid:27)(cid:22)(cid:21)(cid:15)(cid:24)(cid:22)(cid:22) (cid:178)
Other liabilities 479,746 613,673
Total Liabilities 6,212,701 5,350,717
Stockholders’ Equity:
Preferred stock:
$0.01 par value, authorized 5,000,000 shares; none issued or outstanding — —
Common stock:
$0.0005 par value, 250,000,000 shares authorized; 163,602,067 shares issued for both
periods 82 82
Additional paid-in capital 1,899,273 1,823,710
Accumulated other comprehensive loss, net (77,938) (39,867)
Accumulated earnings 1,988,722 1,755,432
Treasury stock, at cost, 74,444,288 and 73,899,977 common shares, respectively (2,871,546) (2,688,600)
Total Stockholders’ Equity 938,593 850,757
Total Liabilities and Stockholders’ Equity $ 7,151,294 $ 6,201,474
See Notes to Consolidated Financial Statements.
43
Page#2
GARTNER, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(IN THOUSANDS, EXCEPT PER SHARE DATA)
Year Ended December 31,
2019 2018 2017
Revenues:
Research $ 3,374,548 $ 3,105,764 $ 2,471,280
Conferences 476,869 410,461 337,903
Consulting 393,904 353,667 327,661
Other — 105,562 174,650
Total revenues 4,245,321 3,975,454 3,311,494
Costs and expenses:  
Cost of services and product development 1,550,568 1,468,800 1,320,198
Selling, general and administrative 2,103,424 1,884,141 1,599,004
Depreciation 82,066 68,592 63,897
Amortization of intangibles 129,713 187,009 176,274
Acquisition and integration charges 9,463 107,197 158,450
Total costs and expenses 3,875,234 3,715,739 3,317,823
Operating income (loss) 370,087 259,715 (6,329)
Interest income 3,026 2,566 3,011
Interest expense (102,831) (126,774) (127,947)
(Loss) gain from divested operations (2,075) (cid:23)(cid:24)(cid:15)(cid:23)(cid:23)(cid:26) (cid:178)
Other income, net 7,532 167 3,448
Income (loss) before income taxes 275,739 181,121 (127,817)
Provision (benefit) for income taxes 42,449 58,665 (131,096)
Net income $ 233,290 $ 122,456 $ 3,279
Net income per share: 
Basic $ 2.60 $ 1.35 $ 0.04
Diluted $ 2.56 $ 1.33 $ 0.04
Weighted average shares outstanding:  
Basic 89,817 90,827 88,466
Diluted 90,971 92,122 89,790
See Notes to Consolidated Financial Statements.
44
Page#3
GARTNER, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(IN THOUSANDS)
Year Ended December 31,
2019 2018 2017
Operating activities: 
Net income $ 233,290 $ 122,456 $ 3,279
Adjustments to reconcile net income to net cash provided by operating activities: 
Depreciation and amortization 211,779 255,601 240,171
Stock-based compensation expense 69,008 66,172 78,943
Deferred taxes (55,787) 1,524 (217,414)
Loss (gain) from divested operations 2,075 (45,447) —
Gain on sale of an equity security (cid:11)(cid:28)(cid:15)(cid:20)(cid:21)(cid:19)(cid:12) (cid:178) (cid:178)
Reduction in the carrying amount of operating lease right-of-use assets (cid:27)(cid:25)(cid:15)(cid:23)(cid:25)(cid:25) (cid:178) (cid:178)
Amortization and write-off of deferred financing fees 6,497 13,815 15,062
Changes in assets and liabilities, net of acquisitions and divestitures:  
Fees receivable, net (66,729) (115,003) (368,516)
Deferred commissions (30,315) (31,247) (61,393)
Prepaid expenses and other current assets 18,985 (50,551) 13,251
Other assets (27,303) 11,456 (18,529)
Deferred revenues 181,203 187,147 382,852
Accounts payable and accrued and other liabilities (54,613) 55,235 186,811
Cash provided by operating activities 565,436 471,158 254,517
Investing activities:  
Additions to property, equipment and leasehold improvements (149,016) (126,873) (110,765)
Acquisitions - cash paid (net of cash acquired) (cid:11)(cid:21)(cid:24)(cid:15)(cid:28)(cid:27)(cid:28)(cid:12) (cid:11)(cid:20)(cid:24)(cid:15)(cid:27)(cid:24)(cid:24)(cid:12) (cid:11)(cid:21)(cid:15)(cid:25)(cid:23)(cid:20)(cid:15)(cid:26)(cid:27)(cid:19)(cid:12)
Divestitures - cash received (net of cash transferred) (cid:178) (cid:24)(cid:21)(cid:25)(cid:15)(cid:26)(cid:26)(cid:28) (cid:178)
Proceeds from the sale of an equity security (cid:20)(cid:23)(cid:15)(cid:20)(cid:21)(cid:19) (cid:178) (cid:178)
Cash (used in) provided by investing activities (160,885) 384,051 (2,752,545)
Financing activities:  
Proceeds from employee stock purchase plan 17,629 14,689 11,711
Proceeds from borrowings 5,000 — 3,025,000
Payments for deferred financing fees — — (51,171)
Payments on borrowings (109,579) (1,010,972) (404,438)
Purchases of treasury stock (199,042) (260,832) (41,272)
Cash (used in) provided by financing activities (285,992) (1,257,115) 2,539,830
Net increase (decrease) in cash and cash equivalents and restricted cash 118,559 (401,906) 41,802
Effects of exchange rates on cash and cash equivalents and restricted cash 3,614 (6,489) 25,902
Cash and cash equivalents and restricted cash, beginning of year 158,663 567,058 499,354
Cash and cash equivalents and restricted cash, end of year $ 280,836 $ 158,663 $ 567,058
Supplemental disclosures of cash flow information: 
Cash paid during the year for: 
Interest $ 102,298 $ 117,500 $ 98,500
Income taxes, net of refunds received $ 119,156 $ 95,800 $ 76,100
See Notes to Consolidated Financial Statements.
47